D. Lipsker, The Schnitzler syndrome, Orphanet Journal of Rare Diseases, vol.5, issue.1, p.38, 2010.
DOI : 10.1186/1750-1172-5-38
URL : https://hal.archives-ouvertes.fr/inserm-00663708

A. Simon, B. Asli, M. Braun-falco, D. Koning, H. Fermand et al., Schnitzler's syndrome: diagnosis, treatment, and follow-up, Allergy, vol.129, issue.5 Suppl, pp.562-570, 2013.
DOI : 10.1111/all.12129

L. Schnitzler, Lesions urticariennes chroniques permanentes (erytheme petaloide?) Cas cliniques, no. 46 B. Journee Dermatologique d'Angers, pp.28-1972

L. Schnitzler, D. Hurez, and J. Verret, Urticaire chronique-osteocodensation-macroglobulinemie. Cas princeps. Etude sur 20 ans, Ann Dermatol Venereol, vol.116, pp.547-50, 1989.

T. Jain, C. Offord, R. Kyle, and D. Dingli, Schnitzler syndrome: an under-diagnosed clinical entity, Haematologica, vol.98, issue.10, pp.1581-1586, 2013.
DOI : 10.3324/haematol.2013.084830

K. Claes, B. Bammens, M. Delforge, P. Evenepoel, D. Kuypers et al., Another devastating complication of the Schnitzler syndrome: AA amyloidosis, British Journal of Dermatology, vol.193, issue.0, pp.182-186, 2008.
DOI : 10.1016/j.clim.2005.10.013

H. De-koning, E. Bodar, J. Van-der-meer, and A. Simon, Schnitzler Syndrome: Beyond the Case Reports: Review and Follow-Up of 94 Patients with an Emphasis on Prognosis and Treatment, Seminars in Arthritis and Rheumatism, vol.37, issue.3, pp.137-185, 2007.
DOI : 10.1016/j.semarthrit.2007.04.001

V. Martinez-taboada, A. Fontalba, R. Blanco, and J. Fernández-luna, Successful treatment of refractory Schnitzler syndrome with anakinra: Comment on the article by Hawkins et al, Arthritis & Rheumatism, vol.364, issue.7, pp.2226-2233, 2005.
DOI : 10.1002/art.21101

J. Gran, Ø. Midtvedt, S. Haug, and P. Aukrust, Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature, Scandinavian Journal of Rheumatology, vol.4, issue.1, pp.74-83, 2011.
DOI : 10.3109/03009742.2010.493894

H. De-koning, J. Schalkwijk, J. Van-der-ven-jongekrijg, M. Stoffels, J. Van-der-meer et al., Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome, Annals of the Rheumatic Diseases, vol.129, issue.10, pp.1634-1642, 2013.
DOI : 10.1136/annrheumdis-2012-202192

K. Krause, K. Weller, R. Stefaniak, H. Wittkowski, S. Altrichter et al., Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study, Allergy, vol.129, issue.5 Suppl, pp.943-50, 2012.
DOI : 10.1111/j.1398-9995.2012.02843.x

J. Ryan, H. De-koning, L. Beck, M. Booty, D. Kastner et al., IL-1 blockade in Schnitzler syndrome: Ex vivo findings correlate with clinical remission, Journal of Allergy and Clinical Immunology, vol.121, issue.1, pp.260-262, 2008.
DOI : 10.1016/j.jaci.2007.09.021

C. Pizzirani, S. Falzoni, M. Govoni, L. Corte, R. Donadei et al., Dysfunctional inflammasome in Schnitzler's syndrome, Rheumatology, vol.48, issue.10, pp.1304-1312, 2009.
DOI : 10.1093/rheumatology/kep222

P. Migliorini, D. Corso, I. Tommasi, C. Boraschi, and D. , Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease?, Eur Cytokine Netw, vol.20, pp.108-119, 2009.

D. Launay, V. Dutoit-lefevre, E. Faure, O. Robineau, C. Hauspie et al., Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome, PLoS ONE, vol.355, issue.3, p.59327, 2013.
DOI : 10.1371/journal.pone.0059327.g002

E. Tinazzi, A. Puccetti, G. Patuzzo, M. Sorleto, A. Barbieri et al., Schnitzler syndrome, an autoimmune???autoinflammatory syndrome: Report of two new cases and review of the literature, Autoimmunity Reviews, vol.10, issue.7, pp.404-413, 2011.
DOI : 10.1016/j.autrev.2011.01.003

K. Krause, E. Feist, M. Fiene, T. Kallinich, and M. Maurer, Complete remission in 3 of 3 anti-IL-6???treated patients with Schnitzler syndrome, Journal of Allergy and Clinical Immunology, vol.129, issue.3, pp.848-50, 2012.
DOI : 10.1016/j.jaci.2011.10.031

O. Sokumbi, L. Drage, and M. Peters, Clinical and histopathologic review of Schnitzler syndrome: The Mayo Clinic experience (1972-2011), Journal of the American Academy of Dermatology, vol.67, issue.6, pp.1289-95, 2012.
DOI : 10.1016/j.jaad.2012.04.027

D. Lipsker, Y. Veran, F. Grunenberger, B. Cribier, E. Heid et al., The Schnitzler Syndrome, Medicine, vol.80, issue.1, pp.37-44, 2001.
DOI : 10.1097/00005792-200101000-00004
URL : https://hal.archives-ouvertes.fr/inserm-00663708

B. Asli, B. Bienvenu, F. Cordoliani, J. Brouet, Y. Uzunhan et al., Chronic Urticaria and Monoclonal IgM Gammopathy (Schnitzler Syndrome), Archives of Dermatology, vol.143, issue.8, pp.1046-50, 2007.
DOI : 10.1001/archderm.143.8.1046

E. Terpos, B. Asli, D. Christoulas, J. Brouet, E. Kastritis et al., Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome, Haematologica, vol.97, issue.11, pp.1699-703, 2012.
DOI : 10.3324/haematol.2012.067306

H. Longhurst, P. Yong, A. Manson, J. Cavenagh, S. Grigoriadou et al., Mullins??? syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra, QJM, vol.108, issue.6, 2012.
DOI : 10.1093/qjmed/hcs208

K. Lee and C. Grattan, Intracostal neuralgia as a previously undescribed symptom of Schnitzler???s syndrome, British Journal of Dermatology, vol.15, issue.6, pp.1392-1395, 2012.
DOI : 10.1111/j.1365-2133.2012.11057.x

T. Volz, F. Wölbing, J. Fischer, M. Braun, I. Maggoschitz et al., Dermal Interleukin-1 Expression and Effective and Long-lasting Therapy with Interleukin-1 Receptor Antagonist Anakinra in Schnitzler Syndrome, Acta Dermato Venereologica, vol.92, issue.4, pp.393-397, 2012.
DOI : 10.2340/00015555-1307

C. Larocca, J. Mcevoy, C. Ellis, J. Junkins-hopkins, T. Kolb et al., Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation, Clinical Rheumatology, vol.117, issue.1, pp.169-74, 2012.
DOI : 10.1007/s10067-011-1804-4

A. Sedivá, A. Polou?ková, M. Podrazil, E. Fro?ková, and K. T. , Characterization of the B-cell compartment in a patient with Schnitzler syndrome, Scandinavian Journal of Rheumatology, vol.17, issue.2, pp.158-60, 2011.
DOI : 10.3109/03009742.2010.507219

P. Szturz, Z. Adam, R. Hájek, and J. Mayer, Successful Anakinra Therapy in 2 Patients with Schnitzler Syndrome, Onkologie, vol.34, issue.5, pp.265-273, 2011.
DOI : 10.1159/000327816

G. Nuki, B. Bresnihan, M. Bear, and D. Mccabe, Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.46, issue.11, pp.2838-2884, 2002.
DOI : 10.1002/art.10578

M. Gerfaud-valentin, Y. Jamilloux, J. Iwaz, and P. Sève, Adult-onset Still's disease, Autoimmunity Reviews, vol.13, issue.7, pp.708-730, 2014.
DOI : 10.1016/j.autrev.2014.01.058

K. Laskari, A. Tzioufas, and H. Moutsopoulos, Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study, Arthritis Research & Therapy, vol.13, issue.3, p.91, 2011.
DOI : 10.1084/jem.20050473

R. Caorsi, S. Federici, and M. Gattorno, Biologic drugs in autoinflammatory syndromes, Autoimmunity Reviews, vol.12, issue.1, pp.81-87, 2012.
DOI : 10.1016/j.autrev.2012.07.027

D. Saadoun, B. Bodaghi, B. Bienvenu, B. Wechsler, D. Sene et al., Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies, Autoimmunity Reviews, vol.12, issue.7, pp.774-83, 2013.
DOI : 10.1016/j.autrev.2013.02.002

S. Maestroni, D. Corato, P. Cumetti, D. Chiara, D. Ghidoni et al., Recurrent pericarditis: Autoimmune or autoinflammatory?, Autoimmunity Reviews, vol.12, issue.1, pp.60-65, 2012.
DOI : 10.1016/j.autrev.2012.07.023

E. Ghogomu and P. Tugwell, Biologics for rheumatoid arthritis: an overview of Cochrane reviews, Cochrane Database Syst Rev, issue.4, p.7848, 2009.

J. Verret, C. Leclech, M. Rousselet, D. Hurez, and L. Schnitzler, Schnitzler syndrome and Waldenström's disease. Fatal outcome of the original case, Ann Dermatol Venereol, vol.120, pp.459-60, 1993.

L. Obici and G. Merlini, Amyloidosis in autoinflammatory syndromes, Autoimmunity Reviews, vol.12, issue.1, pp.14-21, 2012.
DOI : 10.1016/j.autrev.2012.07.016

I. Koné-paut and M. Piram, Targeting interleukin-1?? in CAPS (cryopyrin-associated periodic) syndromes, Autoimmunity Reviews, vol.12, issue.1, pp.77-80, 2012.
DOI : 10.1016/j.autrev.2012.07.026